SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-079797
Filing Date
2020-07-01
Accepted
2020-07-01 17:12:56
Documents
2
Effectiveness Date
2020-07-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2023902-2_defa14a.htm DEFA14A 15480
2 GRAPHIC tm2023902-2_defa14aimg001.jpg GRAPHIC 352869
  Complete submission text file 0001104659-20-079797.txt   502316
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-35963 | Film No.: 201006039
SIC: 2834 Pharmaceutical Preparations